Feasibility of re‐biopsy and EGFR mutation analysis in patients with non‐small cell lung cancer

BACKGROUND: In cases of EGFR‐tyrosine kinase inhibitor (TKI) failure, re‐biopsy may be useful to understand resistance mechanisms and guide further treatment decisions. However, performing re‐biopsy is challenging because of several hurdles. We assessed the feasibility of re‐biopsy in advanced non‐s...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Thorac Cancer
Huvudupphovsmän: Kim, Tae‐Ok, Oh, In‐Jae, Kho, Bo Gun, Park, Ha Young, Chang, Jin Sun, Park, Cheol‐Kyu, Shin, Hong‐Joon, Lim, Jung‐Hwan, Kwon, Yong‐Soo, Kim, Yu‐Il, Lim, Sung‐Chul, Kim, Young‐Chul, Choi, Yoo‐Duk
Materialtyp: Artigo
Språk:Inglês
Publicerad: John Wiley & Sons Australia, Ltd 2018
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6026616/
https://ncbi.nlm.nih.gov/pubmed/29761660
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.12762
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk